CLINICAL_TRIALS
research
· 2026-01-09
Clinical Trial Update: Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease [Phase 1]
Summary
A Phase 1 clinical trial evaluating panobinostat (LBH589) in patients with sickle cell disease is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abdullah Kutlar | Conditions: Sickle Cell Disease | Phase 1 | Status: RECRUITING